ghk-cu levels drop with age plasma decline The first order degradation profiles of in various medium stored ghk-cu levels in human plasma – ghk-cu endogenous levels decline with

Animal studies show substantial evidence across stroke models (full functional recovery in spatial memory, motor coordination, balance), Parkinsons models (protection of dopaminergic neurons, near-complete prevention of mortality), multiple sclerosis models (significantly less brain damage), and traumatic brain injury (reduced hemorrhage and edema)

Simple, effective, time-tested [1]

Be the first to review Thanks for your review

The peptide protocols I prescribe are dosed by me, sourced through a US cGMP-certified compounding pharmacy, and integrated into the same surgical recovery plan I have built operating on out of town and international patients for the last fifteen years

The significant up-regulation of Egr1 and Vegfr2 suggests that BPC 157 has vascularising properties, a mechanism that may underlie its ability to regulate ischaemic/recongestive injury